Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pancreatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Neoplasms 3Colorectal Neoplasms 3Lung Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Sarcoma 1Rectal Neoplasms 1Pancreatic Cancer Resectable 1Lymphangioleiomyomatosis 1Leukemia, Lymphocytic, Chronic, B-Cell 1Gliosarcoma 1Glioblastoma 1Colonic Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms, Male 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Arthritis, Rheumatoid 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Temozolomide 53Bevacizumab 33Radiotherapy 27Radiation 12Erlotinib Hydrochloride 12Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Irinotecan 6Vorinostat 5Sorafenib 5Sirolimus 5temsirolimus 4Magnetic Resonance Spectroscopy 4Immunoglobulin G 4Disulfides 4Carmustine 4veliparib 3plerixafor 3carmustine, poliferprosan 20 drug combination 3Radiosurgery 3Everolimus 3Dasatinib 3Bortezomib 3vandetanib 2tandutinib 2sargramostim 2poly ICLC 2pembrolizumab 2pazopanib 2ferric pyrophosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gliosarcoma × Hydroxychloroquine × Clear all
NCT00486603 2019-07-10

Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
92 enrolled 18 charts
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡